ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
J

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib in Resectable NSCLC With MET Exon 14 Skipping Mutation or High MET Amplification

By ASCO 2022 Conference Coverage FEATURING Jay Lee
By ASCO 2022 Conference Coverage FEATURING Jay Lee
950 views
June 8, 2022
0 Comments
Login to view comments. Click here to Login
Lung
01:24
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

Feat. L. Paz-Ares
10:59
ASCO 2022 Conference Coverage

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

Feat. L. Paz-Ares
01:21
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …

Feat. F. de Marinis
12:27
ASCO 2022 Conference Coverage

ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…

Feat. F. de Marinis
01:08
ASCO 2022 Conference Coverage

Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…

Feat. L. Wirth
10:01
ASCO 2022 Conference Coverage

ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…

Feat. L. Wirth
01:46
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

Feat. L. Paz-Ares
09:18
ASCO 2022 Conference Coverage

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

Feat. L. Paz-Ares
26:58
ASCO 2022 Conference Coverage

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

Feat. J. Varlotto
48
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…

Feat. J. Varlotto
06:33
ASCO 2022 Conference Coverage

ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC

Feat. L. Raez
55
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …

Feat. L. Raez
01:06
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…

Feat. R. Gentzler
01:28
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

Feat. B. Chul Cho
07:37
ASCO 2022 Conference Coverage

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

Feat. B. Chul Cho
05:02
ASCO 2022 Conference Coverage

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

Feat. L. Mazzeo, M. Occhipinti
01:09
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…

Feat. J. Goldschmidt
14:23
ASCO 2022 Conference Coverage

ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…

Feat. J. Goldschmidt
04:31
ASCO 2022 Conference Coverage

ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC

Feat. N. Robert
06:43
ASCO 2022 Conference Coverage

ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…

Feat. J. Heymach
01:17
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…

Feat. J. Heymach
20:37
Jia Luo

Taking on Goliath: Targeting KRAS in NSCLC

07:03
ASCO 2022 Conference Coverage

ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…

Feat. A. Navarro
05:27
ASCO 2022 Conference Coverage

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …

Feat. R. Camidge
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …

Feat. A. Navarro
23
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…

Feat. R. Camidge
05:57
ASCO 2022 Conference Coverage

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…

Feat. B. Levy
01:18
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

Feat. B. Besse
33
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …

Feat. F. Cappuzzo
04:36
ASCO 2022 Conference Coverage

ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…

Feat. F. Cappuzzo
01:01
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…

Feat. K. Gaebe
15:49
ASCO 2022 Conference Coverage

ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…

Feat. K. Gaebe
25
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…

Feat. J. Sands
04:05
ASCO 2022 Conference Coverage

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

Feat. J. Sands
24
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

Feat. J. Sands
07:37
ASCO 2022 Conference Coverage

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

Feat. J. Sands
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…

Feat. B. Ricciuti
07:54
ASCO 2022 Conference Coverage

ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…

Feat. B. Ricciuti
07:00
ASCO 2022 Conference Coverage

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…

Feat. J. Lee